News and Trends 14 Dec 2021
ATP Blazes US Venture Capital Trail into European Biotech Startups
…for value-for-money opportunities in early-stage European biotech startups. Last week, the life science-focused investor ATP contributed €47M (£40M) to the Series A launch of immunotherapy start-up Adendra Therapeutics, a spin-out…